Current report (26/2019) dated 03.10.2019, time. 16:45 UTC
Warsaw, 3 October 2019
Convening the Extraordinary General Meeting of Shareholders.
Current report (25/2019) dated 25.09.2019, time 12:19 UTC
Warsaw, 25 September 2019
Information on preliminary estimates of financial results made in the course of work on the periodic report.
Current report (24/2019) dated 07.09.2019, time 12:27 UTC
Warsaw, 7 September 2019
Termination of the agreement for the commercialization of recombinant human insulin in the territory of Brazil.